ImmunoGenesis
Developer of immuno-oncology therapeutics designed to create cold tumor treatments. The company specializes in immunotherapies to catalyze effective immune responses in immunologically cold cancers su...
Valuation
$0
Share Price
N/A
Total Raised
$67.2M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+13 other investors